Elevated levels of CXCL12 (or elevated cellular expression of the corresponding receptor CXCR4) have been found in previous studies of patients with SSc, but there are no previous reports of a link to mortality or of disproportionate expression in particular disease subgroups [29–31]. This evidence concerns the gene CXCL12 and systemic sclerosis.